Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
45
PCRX Quote, Financials, Valuation and Earnings
Last price:
$26.01
Seasonality move
:
13.08%
Day range:
$25.56 - $26.19
52-week range:
$18.17 - $27.64
Dividend yield:
0%
P/E ratio:
58.33x
P/S ratio:
1.68x
P/B ratio:
1.54x
Volume:
382.4K
Avg. volume:
801.1K
1-year change:
33.64%
Market cap:
$1.1B
Revenue:
$701M
EPS (TTM):
$0.45
Earnings Data
Next earnings date for PCRX
Feb 26
2026
Most recent earnings per share
$0.12
Missed by $0.53
(Nov 6/2025)
Consensus Estimate
$0.65
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PCRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $200.2M | -- | -- | $0.90 | -- |
| 11/06/2025 | Q3 | $182.3M | $179.5M | $0.12 | $0.65 | -$0.53 |
| 08/05/2025 | Q2 | $182.8M | $181.1M | -$0.11 | $0.71 | -$0.82 |
| 05/08/2025 | Q1 | $175.9M | $168.9M | $0.10 | $0.60 | -$0.49 |
| 02/27/2025 | Q4 | $185.4M | $187.3M | $0.33 | $0.83 | -$0.50 |
| 11/06/2024 | Q3 | $169.5M | $168.6M | -$3.11 | $0.70 | -$3.81 |
| 07/30/2024 | Q2 | $173.7M | $178M | $0.39 | $0.70 | -$0.31 |
| 05/07/2024 | Q1 | $165.7M | $167.1M | $0.19 | $0.62 | -$0.43 |
| 02/29/2024 | Q4 | $180.8M | $181.2M | $0.48 | $0.87 | -$0.39 |
| 11/02/2023 | Q3 | $172.9M | $163.9M | $0.23 | $0.78 | -$0.55 |
| 08/02/2023 | Q2 | -- | $169.5M | $0.49 | -- | -- |
| 05/03/2023 | Q1 | -- | $160.3M | -$0.43 | -- | -- |
| 02/28/2023 | Q4 | -- | $172M | -$0.22 | -- | -- |
| 11/03/2022 | Q3 | -- | $167.5M | -$0.02 | -- | -- |
| 08/03/2022 | Q2 | -- | $169.4M | $0.38 | -- | -- |
| 05/04/2022 | Q1 | -- | $158M | $0.15 | -- | -- |
| 02/24/2022 | Q4 | -- | $159.2M | -$0.12 | -- | -- |
| 11/03/2021 | Q3 | -- | $127.7M | $0.39 | -- | -- |
| 08/03/2021 | Q2 | -- | $135.6M | $0.42 | -- | -- |
| 05/04/2021 | Q1 | -- | $119M | $0.23 | -- | -- |
| 02/25/2021 | Q4 | -- | $131M | $0.32 | -- | -- |
| 10/29/2020 | Q3 | -- | $117.5M | $2.94 | -- | -- |
| 08/06/2020 | Q2 | -- | $75.5M | -$0.17 | -- | -- |
| 05/07/2020 | Q1 | -- | $105.7M | $0.19 | -- | -- |
| 02/20/2020 | Q4 | -- | $122.4M | -$0.12 | -- | -- |
| 11/07/2019 | Q3 | -- | $104.7M | -$0.15 | -- | -- |
| 08/08/2019 | Q2 | -- | $102.6M | $0.06 | -- | -- |
| 05/02/2019 | Q1 | -- | $91.3M | -$0.07 | -- | -- |
| 02/28/2019 | Q4 | -- | $95.1M | $0.20 | -- | -- |
| 11/01/2018 | Q3 | -- | $83.4M | -$0.02 | -- | -- |
| 08/02/2018 | Q2 | -- | $84.1M | $0.06 | -- | -- |
| 05/03/2018 | Q1 | -- | $74.6M | -$0.26 | -- | -- |
| 02/28/2018 | Q4 | -- | $79.1M | $0.11 | -- | -- |
| 11/08/2017 | Q3 | -- | $67.3M | -$0.19 | -- | -- |
| 08/02/2017 | Q2 | -- | $70.9M | -$0.49 | -- | -- |
| 05/04/2017 | Q1 | -- | $69.3M | -$0.52 | -- | -- |
| 03/01/2017 | Q4 | -- | $72.9M | -$0.11 | -- | -- |
| 11/02/2016 | Q3 | -- | $68.4M | -$0.59 | -- | -- |
| 08/04/2016 | Q2 | -- | $69.6M | -$0.21 | -- | -- |
| 05/02/2016 | Q1 | -- | $65.5M | -$0.10 | -- | -- |
| 02/25/2016 | Q4 | -- | -- | -- | -- | -- |
Pacira Biosciences, Inc. Earnings Questions
-
How Much did Pacira Biosciences, Inc. Generate in Revenue Last Quarter?
Pacira Biosciences, Inc. reported $179.5M worth of top line sales in its most recent quarter.
-
Did Pacira Biosciences, Inc. Beat Earnings Last Quarter?
Pacira Biosciences, Inc. announced earnings per share of $0.12 which represents a miss of analyst forecast a $0.65 per share.
-
Is Pacira Biosciences, Inc. Profitable?
Pacira Biosciences, Inc. reported $130.9M that represents $2.94 per share over the last quarter.
-
What is the Analyst Consensus for Pacira Biosciences, Inc. EPS Next Year?
Pacira Biosciences, Inc.'s earnings are forecast to grow from -$2.15 per share to $3.15 per share next year representing an increase of 290.33%.
-
When is Pacira Biosciences, Inc.'s Earnings Date?
Pacira Biosciences, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
